Evaluation of marketing authorization and labels of medicines in 2021 WHO Model List of Essential Medicines for Children in China, the Russian Federation and Brazil

被引：0
|
作者：
Caiyun Li
Luyan Cheng
Xuefang Zhang
Lingli Zhang
Jianzhou Yan
机构：
[1] China Pharmaceutical University,School of International Pharmaceutical Business
[2] China Pharmaceutical University,The Research Center of National Drug Policy and Ecosystem
[3] Nanjing Medical University,School of Pharmacy
来源：
Health Research Policy and Systems | / 22卷
关键词：
Essential medicines for children; Drug labels; China; The Russian Federation; Brazil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Availability and accessibility of cytotoxic medicines in the WHO model list of essential medicines for childhood cancer in low and lower-middle- income countries: a systematic review
    Seneviwickrama, Maheeka
    Denagamagei, Sashini Shehana
    Jayakody, Surangi
    Gunasekera, Sanjeeva
    Liyanage, Guwani
    BMC CANCER, 2025, 25 (01)
  • [42] Are age-appropriate antibiotic formulations missing from the WHO list of essential medicines for children? A comparison study
    Ivanovska, Verica
    Leufkens, Hubert G.
    Rademaker, Carin M. A.
    Zisovska, Elizabeta
    Pijnenburg, Marielle W.
    van Dijk, Liset
    Mantel-Teeuwisse, Aukje K.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2017, 102 (04) : 352 - 356
  • [43] Modern approaches to evaluation of the bioequivalence of drugs belonging to the model list of vitally essential and most important medicines
    I. E. Smekhova
    Pharmaceutical Chemistry Journal, 2011, 44 : 691 - 693
  • [44] MODERN APPROACHES TO EVALUATION OF THE BIOEQUIVALENCE OF DRUGS BELONGING TO THE MODEL LIST OF VITALLY ESSENTIAL AND MOST IMPORTANT MEDICINES
    Smekhova, I. E.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2011, 44 (12) : 691 - 693
  • [45] UTILIZATION OF THE WHO MODEL LIST OF ESSENTIAL MEDICINES (EML) FOR ANTI-NEOPLASTIC DRUGS IN LOW AND MIDDLE INCOME COUNTRIES (LMICS)
    Barr, R.
    Robertson, J.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S216 - S216
  • [46] Inclusion of cryoprecipitate, pathogen-reduced, in the WHO model lists of essential medicines for adults and children: a call for action
    Epstein, Jay S.
    Maryuningsih, Yuyun
    Faber, Jean-Claude
    Smid, W. Martin
    Burnouf, Thierry
    BLOOD TRANSFUSION, 2024, 22 (06) : 481 - 483
  • [47] Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications
    Freerks, Lisa
    Sommerfeldt, Jana
    Loeper, Pia C.
    Klein, Sandra
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 156 : 11 - 19
  • [48] US drug shortages compared to the World Health Organization's Model List of Essential Medicines for Children: A cross-sectional study
    Patel, Ram
    Samiee-Zafarghandy, Samira
    Ziesenitz, Victoria
    Fox, Erin R.
    Anker, John van den
    Ong, Hilary
    Mazer-Amirshahi, Maryann
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (22) : 2012 - 2017
  • [49] Evaluation of Need and Distribution of National Essential Medicines List in Village Clinics: A Cross-sectional Study Based on the Perspective of Village Doctors in China
    Zan Wang
    Rui Chang
    Yin-bo Luo
    Jing Wu
    Qi Wang
    Zu-xun Lu
    Jun-an Liu
    Current Medical Science, 2019, 39 : 663 - 669
  • [50] Evaluation of Need and Distribution of National Essential Medicines List in Village Clinics: A Cross-sectional Study Based on the Perspective of Village Doctors in China
    Wang, Zan
    Chang, Rui
    Luo, Yin-bo
    Wu, Jing
    Wang, Qi
    Lu, Zu-xun
    Liu, Jun-an
    CURRENT MEDICAL SCIENCE, 2019, 39 (04) : 663 - 669
12345